Lantidra (donislecel)
(DONISLECEL)CellTrans Inc.
Usage: LANTIDRA is indicated for adults with Type 1 diabetes experiencing severe hypoglycemia despite intensive management. It should be used with immunosuppression and is not recommended for well-controlled diabetes or those managing hypoglycemic events effectively. Caution is advised in patients with liver disease or prior portal thrombosis.